Your browser doesn't support javascript.
loading
Real-world Outcomes With Rituximab-based Therapy for Posttransplant Lymphoproliferative Disease Arising After Solid Organ Transplant.
Burns, David M; Clesham, Katherine; Hodgson, Yan A; Fredrick, Lynsey; Haughton, Joanna; Lannon, Michelle; Hussein, Hayder; Shin, Jin-Sup; Hollows, Robert J; Robinson, Lisa; Byrne, Catherine; McNamara, Christopher; Vydianath, Bindu; Lennard, Anne L; Fields, Paul; Johnson, Rod; Wright, Josh; Fox, Christopher P; Cwynarski, Kate; Chaganti, Sridhar.
Affiliation
  • Burns DM; Centre for Clinical Haematology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
  • Clesham K; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Hodgson YA; Department of Haematology, University College London Hospital, London, United Kingdom.
  • Fredrick L; Department of Haematology, Nottingham City Hospital, Nottingham, United Kingdom.
  • Haughton J; Department of Haematology, Royal Hallamshire Hospital, Sheffield, United Kingdom.
  • Lannon M; Department of Clinical Haematology, St James's University Hospital, Leeds, United Kingdom.
  • Hussein H; Department of Haematology, Freeman Hospital, Newcastle upon Tyne, United Kingdom.
  • Shin JS; Department of Haematology, Freeman Hospital, Newcastle upon Tyne, United Kingdom.
  • Hollows RJ; Department of Haematology, University College London Hospital, London, United Kingdom.
  • Robinson L; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Byrne C; Department of Haematology, County Hospital Hereford, Hereford, United Kingdom.
  • McNamara C; Department of Renal Medicine, Nottingham City Hospital, Nottingham, United Kingdom.
  • Vydianath B; Department of Haematology, University College London Hospital, London, United Kingdom.
  • Lennard AL; Department of Histopathology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
  • Fields P; Department of Haematology, Freeman Hospital, Newcastle upon Tyne, United Kingdom.
  • Johnson R; Department of Haematology, Guy's and Saint Thomas' Hospital, London, United Kingdom.
  • Wright J; Department of Clinical Haematology, St James's University Hospital, Leeds, United Kingdom.
  • Fox CP; Department of Haematology, Royal Hallamshire Hospital, Sheffield, United Kingdom.
  • Cwynarski K; Department of Haematology, Nottingham City Hospital, Nottingham, United Kingdom.
  • Chaganti S; Department of Haematology, University College London Hospital, London, United Kingdom.
Transplantation ; 104(12): 2582-2590, 2020 12.
Article in En | MEDLINE | ID: mdl-33104308
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organ Transplantation / Rituximab / Antineoplastic Agents, Immunological / Lymphoproliferative Disorders Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Transplantation Year: 2020 Document type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organ Transplantation / Rituximab / Antineoplastic Agents, Immunological / Lymphoproliferative Disorders Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Transplantation Year: 2020 Document type: Article Affiliation country: United kingdom